ASX:AGH

Althea Group (AGH) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
454,046 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Althea Group

Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.

AGH Stock News Headlines

Althea Group Holdings Ltd
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
Althea Group Holdings Ltd Ordinary Shares
Althea Group Holdings Ltd.
I'm A Celeb's Snoochie Shy breaks down
See More Headlines
Receive AGH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Althea Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-20,990,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$28.67 million
Book Value
A$0.04 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.50
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Joshua Michael Fegan
    CEO, MD & Executive Director
  • Mr. Robert Meissner
    CFO & Company Secretary
  • Mr. David Sauer
    General Counsel

AGH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Althea Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Althea Group investors own include South32 (SOUHY), Village Roadshow Limited (VRL.AX) (VRL), Virgin Australia Holdings Limited (VAH.AX) (VAH), TubeMogul (TUBE), Sydney Airport (SYD), Orocobre (ORE), OceanaGold (OGC), Ecofibre (EOF), Clean TeQ (CLQ) and Aurora Cannabis (ACB).

This page (ASX:AGH) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners